This is in contrast to our previous studies in patients with stomach, and colon cancer who showed no appreciable changes of serum IgA level [36, and unpublished] like many other natural and adaptive antibody levels in breast cancer patients [12, 39]. Here, CD79A is linked to breast carcinoma.